Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients

被引:73
|
作者
Andrae, David A. [1 ]
Patrick, Donald L. [2 ]
Drossman, Douglas A. [3 ,4 ]
Covington, Paul S. [1 ]
机构
[1] Furiex Pharmaceut Inc, Morrisville, NC 27560 USA
[2] Univ Washington, Sch Publ Hlth, Dept Hlth Serv, Seattle, WA 98195 USA
[3] Educ & Practice Biopsychosocial Care LLC, Drossman Ctr, Chapel Hill, NC USA
[4] UNC Ctr Funct GI & Motil Disorders, Chapel Hill, NC USA
关键词
IBS-QOL; Patient-reported Outcomes; Psychometrics; HRQOL; Irritable Bowel Syndrome; Diarrhea; Eluxadoline; COEFFICIENT ALPHA; RELIABILITY; VALIDATION;
D O I
10.1186/1477-7525-11-208
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Diarrhea-predominant irritable bowel syndrome (IBS-d) significantly diminishes the health-related quality of life (HRQOL) of patients. Psychological and social impacts are common with many IBS-d patients reporting comorbid depression, anxiety, decreased intimacy, and lost working days. The Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire is a 34-item instrument developed and validated for measurement of HRQOL in non-subtyped IBS patients. The current paper assesses this previously-validated instrument employing data collected from 754 patients who participated in a randomized clinical trial of a novel treatment, eluxadoline, for IBS-d. Methods: Psychometric methods common to HRQOL research were employed to evaluate the IBS-QOL. Many of the historical analyses of the IBS-QOL validations were used. Other techniques that extended the original methods were applied where more appropriate for the current dataset. In IBS-d patients, we analyzed the items and substructure of the IBS-QOL via item reduction, factor structure, internal consistency, reproducibility, construct validity, and ability to detect change. Results: This study supports the IBS-QOL as a psychometrically valid measure. Factor analyses suggested that IBS-specific QOL as measured by the IBS-QOL is a unidimensional construct. Construct validity was further buttressed by significant correlations between IBS-QOL total scores and related measures of IBS-d severity including the historically-relevant Irritable Bowel Syndrome Adequate Relief (IBS-AR) item and the FDA's Clinical Responder definition. The IBS-QOL also showed a significant ability to detect change as evidenced by analysis of treatment effects. A minority of the items, unrelated to the IBS-d, performed less well by the standards set by the original authors. Conclusions: We established that the IBS-QOL total score is a psychometrically valid measure of HRQOL in IBS-d patients enrolled in this study. Our analyses suggest that the IBS-QOL items demonstrate very good construct validity and ability to detect changes due to treatment effects. Furthermore, our analyses suggest that the IBS-QOL items measure a univariate construct and we believe further modeling of the IBS-QOL from an item response theory (IRT) approach under both non-treatment and treatment conditions would greatly further our understanding as item-based methods could be used to develop a short form.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients
    David A Andrae
    Donald L Patrick
    Douglas A Drossman
    Paul S Covington
    [J]. Health and Quality of Life Outcomes, 11
  • [2] MAPPING THE IRRITABLE BOWEL SYNDROME QUALITY OF LIFE MEASURE (IBS-QOL) TO EQ-5D IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHOEA (IBS-D)
    Bjorner, J. B.
    Rendas-Baum, R.
    Carson, R. T.
    Boer, R.
    Tucker, C.
    Andrae, D. A.
    Brazier, J. E.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A379 - A379
  • [3] Item-Level Assessment of the Irritable Bowel Syndrome Quality of Life Questionnaire in Patients With Diarrheal Irritable Bowel Syndrome
    Andrae, David A.
    Covington, Paul S.
    Patrick, Donald L.
    [J]. CLINICAL THERAPEUTICS, 2014, 36 (05) : 663 - 679
  • [4] Health related quality of life in Iranian patients with Irritable Bowel Syndrome: Reliability and validity of the Persian version of the IBS-QOL
    Jafari, Peyman
    Asadollahi, Zahra
    Moini, Maryam
    Mirzaie, Mahdi Seyed
    [J]. IRANIAN RED CRESCENT MEDICAL JOURNAL, 2013, 15 (08) : 723 - 728
  • [5] Development and validation of a quality of life (QOL) tool for irritable bowel syndrome (IBS).
    Depew, W
    Vanner, S
    Paterson, W
    Roblin, N
    Groll, D
    MacKenzie, T
    Da Costa, L
    Groll, A
    Simon, J
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A10 - A10
  • [6] Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome
    Hahn, BA
    Kirchdoerfer, LJ
    Fullerton, S
    Mayer, E
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (03) : 547 - 552
  • [7] Is pain the predominant symptom in irritable bowel syndrome (IBS)?
    Lembo, T
    Fullerton, S
    Mayer, EA
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A705 - A705
  • [8] Content, face, and construct validity of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) as a measure of bowel-related quality of life in spinal cord injury
    Abedi, Aidin
    Kohli, Priya
    Montero, Stefania
    Morales, Luis
    Ha, Nhi
    Abedi, Armita
    La Riva, Anibal
    Ginsberg, David
    Kreydin, Evgeniy
    [J]. NEUROUROLOGY AND URODYNAMICS, 2023, 42 (06) : 1362 - 1373
  • [9] Psychometric Characteristics of the Persian Version of the Irritable Bowel Syndrome Quality of Life Questionnaire (P-IBS-QOL)
    Haghayegh, Sayed Abbas
    Neshatdoost, Hamidtaher
    Drossman, Douglas A.
    Asgari, Karim
    Soulati, Sayed Kamal
    Adibi, Peyman
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2012, 28 (02) : 312 - 317
  • [10] Improvement of quality of life (QOL) of irritable bowel syndrome (IBS) patients by hydrotherapy in Chatel-Guyon.
    Bommelaer, G
    Porte, M
    Marquis, P
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A723 - A723